With Hervør Lykke Olsen, Senior Scientific Business Developer at BII
Creation House is eligible for start-ups within therapeutics, bioindustrials, and health tech. The start-up must have a solid, initial business plan and preliminary proof of concept.
It is a requirement that the company has not received any commercial investments.
Hervør Lykke Olsen, Senior Scientific Business Developer
Hervør has a Ph.D. in health science from Medicon Valley Academy and a background in ion channels and diabetes research in Novo Nordisk. Hervør has worked as a post-doctoral researcher in Switzerland and brings experience from therapeutics and biotech start-ups.
Giles Dudley, Senior Business Developer
Giles has over 10 years of experience working in the start-up environment. He holds a Ph.D. in virology from the MRC Virology Unit at the University of Glasgow and has previously worked with Sunergos Innovations, Edinburgh Bioquarter, and with a number of seed stage healthcare companies.
Cathrine Nygaard Christensen, Funding Specialist
Cathrine holds a master’s degree in international business communication from Copenhagen Business School. She is an experienced consultant who advises start-ups on funding processes and manages the open call process.
EXPLAINED: BII’S CONVERTIBLE LOAN
BII’s convertible loan is a risk-free funding opportunity for early-stage start-ups. It leaves the start-up free from repayment in case the company fails. If the company receives a sizeable investment, BII takes equity by converting shares. BII is a non-profit initiative, and the equity from successful companies returns to BII to continuously support early-stage start-ups that can impact society by bringing new solutions to the market.